08:00 , Jan 5, 2015 |  BC Week In Review  |  Company News

Baruch S. Blumberg Institute, OnCore Biopharma deal

The institute granted OnCore an exclusive, worldwide option to license products resulting from the partners’ collaboration to identify HBV and liver cancer targets, therapies and diagnostics. Under the renewable three-year agreement, the institute will provide...
08:00 , Dec 18, 2014 |  BC Innovations  |  Translation in Brief

YABAO GOES BOLD

Yabao goes bold China-based Yabao Pharmaceutical Group Co. Ltd. and MRC Technology are jointly going where Western pharmas and academics fear to tread with a preclinical partnership to develop compounds against an undisclosed kinase target...